Naltrexone And Bupropion
A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes
Orexigen Therapeutics, Inc · Phase 3 · Completed · Enrollment 505
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| NB32 | 44.53% | 18.49% | n/r | n/r |
| Placebo | 18.87% | 5.66% | n/r | n/r |
Not shown
Every selected arm is drawn.